GD
OGN icon

Grandfield & Dodd’s Organon & Co OGN Stock Holding History

Grandfield & Dodd’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-7,864
Closed -$270K – 200
2022
Q1 		$270K Sell
7,864
-4,759
-38% -$163K 0.02% 177
2021
Q4 		$380K Sell
12,623
-5,893
-32% -$192K 0.02% 160
2021
Q3 		$610K Sell
18,516
-11,269
-38% -$361K 0.04% 122
2021
Q2 		$900K Buy
+29,785
New +$980K 0.06% 106

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Grandfield & Dodd's OGN Position: Q2 2022 in Review

Grandfield & Dodd sold out of Organon & Co (OGN) in Q2 2022, closing a stake of 7,864 shares — an estimated $270K sold.

Grandfield & Dodd first reported a position in OGN in Q2 2021 and held it in 4 quarters. The position peaked at $900K in Q2 2021. 853 funds tracked by Wall St. Rank hold OGN as of Q2 2022.

  • Grandfield & Dodd reported no remaining Organon & Co position as of Q2 2022 after selling out during the quarter.
  • Grandfield & Dodd sold 7,864 Organon & Co shares in Q2 2022, an estimated $270K.
  • Grandfield & Dodd first reported a position in Organon & Co in Q2 2021 and held it in 4 quarters.
  • Grandfield & Dodd's Organon & Co position peaked at $900K in Q2 2021.
  • 853 funds tracked by Wall St. Rank held Organon & Co as of Q2 2022.

Based on Grandfield & Dodd's 13F filing for Q2 2022, filed 1 Aug 2022.